Overview

Bleeding Time Study With AZD6482, Clopidogrel and ASA

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the effect of AZD6482 and clopidogrel on bleeding time when taken together with low-dose ASA.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Clopidogrel
Ticlopidine